NCT03333681View on ClinicalTrials.gov

Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 20, 2016

Primary Completion Date

August 15, 2018

Study Completion Date

September 15, 2018

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Autologous mesenchymal stem cells

A single intravenous administration of autologous bone marrow derived mesenchymal stem cells(1000000 to 2000000 cells/Kg)

All Listed Sponsors
lead

Mashhad University of Medical Sciences

OTHER

NCT03333681 - Evaluation of Stem Cell Therapy Effects on the Immune Response in Rheumatoid Arthritis Patients | Biotech Hunter | Biotech Hunter